Journal
CURRENT MEDICINAL CHEMISTRY
Volume 11, Issue 16, Pages 2213-2243Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867043364658
Keywords
-
Ask authors/readers for more resources
The development of bacterial resistancc is a significant problem in the treatment of infection, and the importance of research directed toward the discovery of novel agents to trea 2213t infections cannot be underestimated. In the past, discovery programs have focused on modification of natural products or existing classes of marketed antibacterial agents. A significant period of time lapsed between the introduction of the nalidixic acid-based quinolones and the next novel antibacterial agent (Zyvox(TM)). However, the advent of the ''genomics era has provided a wealth of new targets that afford the opportunity to discover novel antibacterial agents. This review reports on the state of antibacterial research directed toward the development of novel antibacterial agents with novel mechanisms of action for the calendar year, 2002. While variations on existing drug classes continue to appear, we have chosen to limit Our discussion to novel classes of antibacterial agents which have not yet been marketed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available